| Primary |
| Depression |
58.9% |
| Major Depression |
7.9% |
| Anxiety |
4.1% |
| Panic Attack |
4.1% |
| Affective Disorder |
3.4% |
| Bipolar I Disorder |
2.7% |
| Anticoagulant Therapy |
2.1% |
| Oral Contraception |
2.1% |
| Bipolar Disorder |
1.7% |
| Psychotic Disorder |
1.7% |
| Generalised Anxiety Disorder |
1.4% |
| Mania |
1.4% |
| Panic Disorder |
1.4% |
| Post-traumatic Stress Disorder |
1.4% |
| Social Phobia |
1.4% |
| Coagulopathy |
1.0% |
| Depressed Mood |
1.0% |
| Impulse-control Disorder |
1.0% |
| Adjustment Disorder |
0.7% |
| Asthma |
0.7% |
|
| Loss Of Consciousness |
9.2% |
| Pregnancy |
8.2% |
| Vomiting |
8.2% |
| Hospitalisation |
7.1% |
| Hyponatraemia |
7.1% |
| Somnolence |
6.1% |
| Restlessness |
5.1% |
| Serotonin Syndrome |
5.1% |
| Treatment Noncompliance |
5.1% |
| Convulsion |
4.1% |
| Depression |
4.1% |
| Obesity |
4.1% |
| Therapy Non-responder |
4.1% |
| Urticaria |
4.1% |
| Completed Suicide |
3.1% |
| Drug Interaction |
3.1% |
| Grand Mal Convulsion |
3.1% |
| Leukocytoclastic Vasculitis |
3.1% |
| Nocturia |
3.1% |
| Pregnancy On Oral Contraceptive |
3.1% |
|
| Secondary |
| Depression |
44.2% |
| Panic Attack |
17.3% |
| Major Depression |
9.3% |
| Anxiety |
6.0% |
| Anticoagulant Therapy |
4.0% |
| Postpartum Depression |
4.0% |
| Affective Disorder |
2.7% |
| Coagulopathy |
2.0% |
| Generalised Anxiety Disorder |
1.3% |
| Impulse-control Disorder |
1.3% |
| Mania |
1.3% |
| Post-traumatic Stress Disorder |
1.3% |
| Product Used For Unknown Indication |
1.0% |
| Psychotic Disorder |
1.0% |
| Bipolar I Disorder |
0.7% |
| Drug Use For Unknown Indication |
0.7% |
| Ill-defined Disorder |
0.7% |
| Trigeminal Neuralgia |
0.7% |
| Antiplatelet Therapy |
0.3% |
| Insomnia |
0.3% |
|
| Pregnancy |
15.9% |
| Therapy Non-responder |
11.6% |
| Hospitalisation |
5.8% |
| Hyponatraemia |
5.8% |
| Loss Of Consciousness |
5.8% |
| Rhabdomyolysis |
5.8% |
| Syncope |
5.8% |
| White Blood Cell Count Increased |
5.8% |
| Drug Exposure During Pregnancy |
4.3% |
| Total Cholesterol/hdl Ratio Decreased |
4.3% |
| Depression |
2.9% |
| Myocardial Infarction |
2.9% |
| Nausea |
2.9% |
| Neuroleptic Malignant Syndrome |
2.9% |
| No Therapeutic Response |
2.9% |
| Pruritus |
2.9% |
| Rash Generalised |
2.9% |
| Tearfulness |
2.9% |
| Treatment Noncompliance |
2.9% |
| Umbilical Cord Abnormality |
2.9% |
|
| Concomitant |
| Depression |
16.7% |
| Pain |
16.7% |
| Back Pain |
11.1% |
| Ill-defined Disorder |
11.1% |
| Metastatic Renal Cell Carcinoma |
11.1% |
| Breast Cancer |
5.6% |
| Cerebrovascular Disorder |
5.6% |
| Epilepsy |
5.6% |
| Hypertension |
5.6% |
| Muscle Spasms |
5.6% |
| Neuroendocrine Tumour |
5.6% |
|
| Refusal Of Treatment By Patient |
9.5% |
| Stomatitis |
9.5% |
| Treatment Noncompliance |
9.5% |
| Weight Decreased |
9.5% |
| Death |
4.8% |
| Drug Effect Decreased |
4.8% |
| Dyskinesia |
4.8% |
| Gamma-glutamyltransferase Increased |
4.8% |
| Hepatitis A |
4.8% |
| Mobility Decreased |
4.8% |
| Protein Total Decreased |
4.8% |
| Pulse Pressure Increased |
4.8% |
| Rhabdomyolysis |
4.8% |
| Snoring |
4.8% |
| Swelling Face |
4.8% |
| Urinary Incontinence |
4.8% |
| Weight Increased |
4.8% |
|
